Billede af Birger Brodin Larsen

Birger Brodin Larsen

Lic. scient. (PhD)

1989 …2019

Publikationer pr. år

Netværk

Philipp Berndt

  • Leibniz Institut für Molekulare Physiogie, Campus Berlin-Buch, Berlin, Germany

Ekstern person

Ingolf Blasig

  • Leibniz Institut für Molekulare Physiogie, Campus Berlin-Buch, Berlin, Germany

Ekstern person

Lassina Badolo

  • Neuroscience Drug Discovery Denmark, H. Lundbeck A/S, 9 Ottiliavej, 2500 Copenhagen-Valby, Denmark

Ekstern person

René Holm

  • H. Lundbeck A/S

Ekstern person

Simon Groth

  • Institut for Medicin og Sundhedsteknologi
  • Det Teknisk-Naturvidenskabelige Fakultet, Aalborg Universitet

Ekstern person

Helle Bach Søndergaard

  • FARMA
  • University of Copenhagen

Ekstern person

Rene Holm

  • H.Lundbeck A/S

Ekstern person

K A Rytved

  • University of Copenhagen

Ekstern person

Rasmus Madelung

  • Institut for Farmaci

Ekstern person

Kristine Langthaler

  • H. Lundbeck A/S

Ekstern person

Anne Jensen

  • Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen

Ekstern person

Piotr Siupka

  • Institut for Biomedicin - Forskning og uddannelse, Vest

Ekstern person

Morten Schallburg Nielsen

  • Institut for Biomedicin - Forskning og uddannelse, Vest

Ekstern person

Rene Holm

  • H. Lundbeck A/S

Ekstern person

Klaus Gjervig Jensen

  • H. Lundbeck A/S

Ekstern person

Júlia Rodríguez Sendra

  • Department of Molecular Drug Research, University of Copenhagen

Ekstern person

Rene Holm

  • H. Lundbeck A/S

Ekstern person

Ignacio A Romero

  • Open University Milton Keynes

Ekstern person

Rasmus Koldborg Holm

  • H. Lundbeck A/S

Ekstern person

Jukka Mönkkönen

  • University of Kuopio

Ekstern person

Hazel C Jones

  • Gagle Brook House

Ekstern person

Peter Ifversen

  • Coloplast A/s

Ekstern person

Elin Eneberg

  • H. Lundbeck A/S

Ekstern person

Peder Søndergaard Madsen

  • Institut for Biomedicin - Forskning og uddannelse, Vest

Ekstern person

Anne-Marie Jacobsen

  • H. Lundbeck A/S

Ekstern person

H Sari

  • Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen

Ekstern person

H.M. Oppers-Tiemissen

  • Schering-Plough Corporation

Ekstern person

Andreas Tue Ingemann Jensen

  • The Hevesy Laboratory

Ekstern person

Markus Schwaninger

  • University of Lübeck

Ekstern person

Ralf Mols

  • KU Leuven

Ekstern person

Christina Sveigaard

  • H. Lundbeck A/S

Ekstern person

K. B. Ewon

  • H. Lundbeck A/S

Ekstern person

Martijn Rooseboom

  • Schering-Plough Corporation

Ekstern person

Karin Lykke-Hartmann

  • Institut for Biomedicin - Medicinsk Biokemi

Ekstern person

Pernille Lindskov Krog

  • Danish University of Pharmaceutical Sciences

Ekstern person

M A Kall

  • Department of Early Development Pharmacokinetics, H. Lundbeck A/S

Ekstern person

John Greenwood

  • UCL Institute of Ophthalmology
  • University College London

Ekstern person

Torben Moos

  • Laboratoriet for Neurobiologi

Ekstern person

Anne Højland

  • Institut for Biomedicin - Forskning og uddannelse, Vest

Ekstern person

Dirk Tourwé

  • Vrije Universiteit Brussel

Ekstern person

Simran Kaur

  • University of Melbourne

Ekstern person

Rose Hayeshi

  • AstraZenecha

Ekstern person

Daniela Vullo

  • Università degli Studi di Firenze

Ekstern person

Mette Carstensen

  • Institut for Farmaci

Ekstern person

Alan W Stitt

  • Queen's University Belfast

Ekstern person

Nathalie Maubon

  • Solvay Pharmaceuticals Company

Ekstern person

Egbert Hovenkamp

  • Unilever Food and Health Research Institute

Ekstern person

Eva G.E. Ragnarsson

  • Uppsala University

Ekstern person

Anne-Lena Ungell

  • AstraZeneca

Ekstern person

C. Birer

  • Department of Drug Design and Pharmacology, University of Copenhagen

Ekstern person

L Langthaler

  • Biologics and Pharmaceutical Science, H. Lundbeck A/S, Ottiliavej 9, 2500, Valby, Denmark.

Ekstern person

Lina Fossati

  • Solvay Pharmaceuticals Company

Ekstern person

Chantal Masungi

  • Tibotec BVBA

Ekstern person

Carl Webster

  • MedImmune

Ekstern person

Klaus G. Jensen

  • H. Lundbeck A/S

Ekstern person

Pascale Anderle

  • Laboratory of Experimental Cancer Research

Ekstern person

R Holm

  • Biologics and Pharmaceutical Science, H. Lundbeck A/S, Ottiliavej 9, 2500, Valby, Denmark.

Ekstern person

Jon Våbenø

  • University of Tromsø – The Arctic University of Norway

Ekstern person

Pascale Dehertogh

  • Tibotec BVBA

Ekstern person

Gerda Marie Rist

  • LEO-Pharma

Ekstern person

Flemming Madsen

  • Coloplast A/s

Ekstern person

Michel Khrestchatisky

  • CNRS
  • Aix-Marseille Université

Ekstern person

Karrin Lykke-Hartmann

  • Aarhus University

Ekstern person

Caitriona O´Driscoll

  • University College Cork

Ekstern person

Bjørn Holst

  • Bioneer A/S (Biz)

Ekstern person

René Holm

  • Biologics and Pharmaceutical Science, H. Lundbeck A/S, Ottiliavej 9, 2500, Valby, Denmark.

Ekstern person

Per Arthursson

  • Uppsala University

Ekstern person

Gert Fricker

  • Heidelberg University
  • Heidelberg University 

Ekstern person

Claudiu T Supuran

  • Università degli Studi di Firenze

Ekstern person

Carsten Uhd Nielsen

  • University of Southern Denmark

Ekstern person

René Holm

  • H. Lundbeck A/S

Ekstern person

Andrea Scozzafava

  • Università degli Studi di Firenze

Ekstern person

K. V. Christensen

  • H. Lundbeck A/S

Ekstern person

René Holm

  • H.Lundbeck A/S

Ekstern person

Timo Korjamo

  • University of Kuopio

Ekstern person

Constanze Hilgendorf

  • AstraZenecha

Ekstern person

Helle Bach Søndergaard

  • Danish Multiple Sclerosis Research Center
  • University of Copenhagen

Ekstern person

Karen Fisher

  • University College Cork

Ekstern person

Jan Amstrup

  • Zoophysiological Laboratory, August Krogh Institute, University of Copenhagen, Universitetsparken 13, DK-2100, Copenhagen Ø

Ekstern person

Torben Moos

  • Institut for Medicin og Sundhedsteknologi
  • Faggruppen for Biomedicin
  • Det Sundhedsvidenskabelige Fakultet, Københavns Universitet
  • Laboratoriet for Neurobiologi

Ekstern person

Steven Ballet

  • Vrije Universiteit Brussel

Ekstern person

Pieter J Gaillard

  • 2-BBB Medicines BV

Ekstern person

Ingrid Hausser

  • Universitäts-Hautklinik

Ekstern person

Silvina A. Bravo

  • ETH Zurich

Ekstern person

K. G. Jensen

  • H. Lundbeck A/S

Ekstern person

Stephen T Buckley

  • Novo Nordisk Foundation

Ekstern person

Stephen Buckley

  • University of York

Ekstern person

R. Larsen

  • H. Lundbeck A/S

Ekstern person

René Holm

  • Biologics and Pharmaceutical Science, H. Lundbeck A/S, Ottiliavej 9, 2500, Valby, Denmark.

Ekstern person

Margareta Hammarlund-Udenaes

  • Uppsala University

Ekstern person

M. A. Kall

  • H. Lundbeck A/S

Ekstern person

Heiko Manninga

  • NEUWAY Pharma GmbH

Ekstern person

Dino Montanari

  • H. Lundbeck A/S

Ekstern person

Krzysztof B Wicher

  • Ossianix Inc.

Ekstern person

Lars Olsen

  • Danish University of Pharmaceutical Sciences

Ekstern person

S Abdulhadi

  • Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen

Ekstern person

Tue Søborg

  • Lægemiddelstyrelsen

Ekstern person